| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 1.10e-04 | 15 | 21 | 2 | GO:0004029 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 1.42e-04 | 17 | 21 | 2 | GO:0004030 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.15e-03 | 48 | 21 | 2 | GO:0016620 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.57e-03 | 56 | 21 | 2 | GO:0016903 | |
| GeneOntologyMolecularFunction | NAD binding | 2.65e-03 | 73 | 21 | 2 | GO:0051287 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 7.27e-05 | 14 | 19 | 2 | GO:2001046 | |
| MousePheno | increased thoracic vertebrae number | 6.23e-05 | 10 | 17 | 2 | MP:0004651 | |
| MousePheno | increased presacral vertebrae number | 1.08e-04 | 13 | 17 | 2 | MP:0000464 | |
| Domain | LIM | 7.90e-07 | 69 | 20 | 4 | PF00412 | |
| Domain | LIM_DOMAIN_2 | 8.87e-07 | 71 | 20 | 4 | PS50023 | |
| Domain | Znf_LIM | 8.87e-07 | 71 | 20 | 4 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 8.87e-07 | 71 | 20 | 4 | PS00478 | |
| Domain | LIM | 8.87e-07 | 71 | 20 | 4 | SM00132 | |
| Domain | TCR | 1.09e-06 | 2 | 20 | 2 | PF03638 | |
| Domain | Lin-54_fam | 1.09e-06 | 2 | 20 | 2 | IPR028307 | |
| Domain | CRC | 1.09e-06 | 2 | 20 | 2 | PS51634 | |
| Domain | CRC | 1.09e-06 | 2 | 20 | 2 | IPR005172 | |
| Domain | PINCH | 3.27e-06 | 3 | 20 | 2 | IPR017351 | |
| Domain | EGF | 4.02e-06 | 235 | 20 | 5 | SM00181 | |
| Domain | EGF-like_dom | 5.33e-06 | 249 | 20 | 5 | IPR000742 | |
| Domain | Tesmin/TSO1-like_CXC | 1.63e-05 | 6 | 20 | 2 | IPR033467 | |
| Domain | CXC | 1.63e-05 | 6 | 20 | 2 | SM01114 | |
| Domain | - | 5.49e-05 | 70 | 20 | 3 | 2.10.110.10 | |
| Domain | Ald_DH_CS_GLU | 1.30e-04 | 16 | 20 | 2 | IPR029510 | |
| Domain | EGF_1 | 1.38e-04 | 255 | 20 | 4 | PS00022 | |
| Domain | Ald_DH_CS_CYS | 1.47e-04 | 17 | 20 | 2 | IPR016160 | |
| Domain | EGF-like_CS | 1.51e-04 | 261 | 20 | 4 | IPR013032 | |
| Domain | EGF_2 | 1.60e-04 | 265 | 20 | 4 | PS01186 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.65e-04 | 18 | 20 | 2 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.65e-04 | 18 | 20 | 2 | PS00070 | |
| Domain | - | 1.84e-04 | 19 | 20 | 2 | 3.40.605.10 | |
| Domain | Aldedh | 1.84e-04 | 19 | 20 | 2 | PF00171 | |
| Domain | Aldehyde_DH_dom | 1.84e-04 | 19 | 20 | 2 | IPR015590 | |
| Domain | - | 1.84e-04 | 19 | 20 | 2 | 3.40.309.10 | |
| Domain | Ald_DH_C | 1.84e-04 | 19 | 20 | 2 | IPR016163 | |
| Domain | Ald_DH_N | 1.84e-04 | 19 | 20 | 2 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 1.84e-04 | 19 | 20 | 2 | IPR016161 | |
| Domain | EGF | 3.14e-04 | 126 | 20 | 3 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 5.87e-04 | 156 | 20 | 3 | IPR009030 | |
| Domain | EGF_3 | 1.91e-03 | 235 | 20 | 3 | PS50026 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 3.14e-04 | 29 | 13 | 2 | M12524 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 3.60e-04 | 31 | 13 | 2 | M39714 | |
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 23484127 | ||
| Pubmed | ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. | 1.90e-05 | 11 | 21 | 2 | 23142317 | |
| Pubmed | Age of onset of amyotrophic lateral sclerosis is modulated by a locus on 1p34.1. | 7.24e-05 | 21 | 21 | 2 | 22959728 | |
| Pubmed | 8.72e-05 | 23 | 21 | 2 | 18971422 | ||
| Pubmed | 4.37e-04 | 608 | 21 | 4 | 16713569 | ||
| Interaction | TRIM49C interactions | 1.96e-05 | 7 | 20 | 2 | int:TRIM49C | |
| Interaction | IGFL3 interactions | 5.39e-05 | 75 | 20 | 3 | int:IGFL3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 3.36e-04 | 59 | 21 | 2 | chr2q13 | |
| Cytoband | 2q13 | 4.46e-04 | 68 | 21 | 2 | 2q13 | |
| GeneFamily | LIM zinc finger domain containing|LIM domain containing | 3.31e-09 | 4 | 18 | 3 | 1163 | |
| GeneFamily | LIM domain containing | 2.60e-05 | 59 | 18 | 3 | 1218 | |
| GeneFamily | Aldehyde dehydrogenases | 1.58e-04 | 19 | 18 | 2 | 398 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Fos_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.42e-08 | 80 | 21 | 4 | b661644806e225f215047e78ae46d7cee6efde4f | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-06 | 176 | 21 | 4 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Nxph2_Wls|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.02e-05 | 130 | 21 | 3 | 05d5a73acf1d7f75a79876b1a06d27c74a89b8a4 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.61e-05 | 138 | 21 | 3 | c172880eda7b8b8b758dbbc77f93191238f3181c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.68e-05 | 139 | 21 | 3 | 313f7e66ed94950129c7146a2afe2feb8951fe1e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 142 | 21 | 3 | 6469cf82552b39f63e20b841c9eed50de6f58d54 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.10e-05 | 155 | 21 | 3 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.03e-05 | 164 | 21 | 3 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.82e-05 | 171 | 21 | 3 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 6.94e-05 | 172 | 21 | 3 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.06e-05 | 173 | 21 | 3 | 9c7386bf0a899882c733f0b4921a96afde032a7d | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_12|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.06e-05 | 173 | 21 | 3 | a55f310c533432e9e26e400026a5b47245152976 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 174 | 21 | 3 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.43e-05 | 176 | 21 | 3 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.56e-05 | 177 | 21 | 3 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.81e-05 | 179 | 21 | 3 | 2b5f8e109a67c7fc3ec2b83e8f1854160c99283a | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-tDC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.94e-05 | 180 | 21 | 3 | 3d9f3e6f13e558279b4ef43e2c44c7c50d761745 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 8.34e-05 | 183 | 21 | 3 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.34e-05 | 183 | 21 | 3 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | Control-Endothelial-Endothelial-Artery|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-05 | 186 | 21 | 3 | 2d3a975d2bf92e18e3410dd413fc9f84831d82de | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.75e-05 | 186 | 21 | 3 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.03e-05 | 188 | 21 | 3 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-DC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.03e-05 | 188 | 21 | 3 | c1b8682f2edb45d51bf91ebf429dff1cb57a7a73 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.03e-05 | 188 | 21 | 3 | 15d8dc514d5da46f6af284e7c1c92c606712dae6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.47e-05 | 191 | 21 | 3 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 192 | 21 | 3 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.62e-05 | 192 | 21 | 3 | 8ad6678df89175c5a4a835c8566f1552df3c996e | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 192 | 21 | 3 | 450baeb5c3df7a9445472530002ce38f177a333c | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.62e-05 | 192 | 21 | 3 | 2f5378ea0b2fb2f672a36585d375f675983363a1 | |
| ToppCell | distal-Hematologic-Basophil/Mast_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.76e-05 | 193 | 21 | 3 | f22d0a2ea6bbdd625909ccb6a89aca89ab670306 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 9.76e-05 | 193 | 21 | 3 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.76e-05 | 193 | 21 | 3 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | distal-Hematologic-Basophil/Mast_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.76e-05 | 193 | 21 | 3 | dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78 | |
| ToppCell | distal-3-Hematologic-Basophil/Mast_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.76e-05 | 193 | 21 | 3 | 23c6c798525dad43eff792727902ea562bf373be | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.91e-05 | 194 | 21 | 3 | 6be74e4ba631b0c46cef2c580553f4c1ed29579e | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.91e-05 | 194 | 21 | 3 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC2|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 194 | 21 | 3 | a0cfc8c1cdc0722db39170e4417615b6e6b85041 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.91e-05 | 194 | 21 | 3 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | LA-14._Fibroblast_III|World / Chamber and Cluster_Paper | 9.91e-05 | 194 | 21 | 3 | 803fa83ceada17c38ca9f933b888f7e7b0b90761 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.91e-05 | 194 | 21 | 3 | 54975e663ed4414b99b3c9a1aa6335613946470f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_DC-DC-DC2|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.91e-05 | 194 | 21 | 3 | 833c695779edc94690b08814b0dedcf00ae082cd | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.91e-05 | 194 | 21 | 3 | c47fc3f716ab091a39c20d7639ac783029589ee5 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.01e-04 | 195 | 21 | 3 | 62d369a8af2b76a2553bc8ff9cb89a133b060123 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 195 | 21 | 3 | 2394e75cf493d8bc2e638ecb425386265176dd41 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-04 | 197 | 21 | 3 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.04e-04 | 197 | 21 | 3 | 6852a8ec1397811bbdd1fc625c52ed4fa75a931e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-04 | 197 | 21 | 3 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | tumor_Lung-Epithelial_cells-tS1|Epithelial_cells / Location, Cell class and cell subclass | 1.04e-04 | 197 | 21 | 3 | 7190143468939cf26c069d125a5e88e4bf026299 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.04e-04 | 197 | 21 | 3 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | distal-Epithelial-Club-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.05e-04 | 198 | 21 | 3 | e56a5ffadfa4d1e34d34aec43eaf560cd80286e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 198 | 21 | 3 | 0d9d401190792fd61434f1b82548253187d805f0 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-04 | 198 | 21 | 3 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 198 | 21 | 3 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-04 | 199 | 21 | 3 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | distal-Epithelial-Club|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-04 | 199 | 21 | 3 | c63ccce1285352927fd8c4f7374ec5fff8d70cec | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.07e-04 | 199 | 21 | 3 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | severe-cDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.08e-04 | 200 | 21 | 3 | 23e3d2fb86a71f62cca32640842fbba5dd163453 | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 1.08e-04 | 200 | 21 | 3 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.08e-04 | 200 | 21 | 3 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.11e-04 | 64 | 21 | 2 | 3e3eed30abcecd3fc8d30489dca05222ac353180 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.11e-04 | 64 | 21 | 2 | 2edc3ae3e334bb04a411778e3b102b3a84a97824 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Kctd12-Inhibitory_Gad1Gad2Slc17a8_Htr3a.Ktcd12_(Interneuron,__GABA/Glutamate_co-releasing?_(candidate_CGE-derived_9))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.11e-04 | 64 | 21 | 2 | b8aac6e83c2e5b09b55ea22ddb29940099f186e1 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.06e-04 | 71 | 21 | 2 | 2220e1b02baa71961cfc85536bafeb313e588bf3 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1-Tnr-Polydendrocyte.Tnr.Pdgfa-Pik3r3_(Pdgfa)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 5.06e-04 | 71 | 21 | 2 | cc5de8bbcfefa2bf93cc137c74b49a745d5da229 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2-Excitatory_Neuron.Slc17a7-Slc17a8.Fezf2-Slc17a8_(Layer_5,_Retrosplenial_cortex_(RSG)_and_Subiculum,_Tshz2+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.20e-04 | 72 | 21 | 2 | e3f4d1df43cc41b0424f27485a00ddca9e905f95 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 3aa95bf2d8ac37e648037faf3d54ebb243a4fde1 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 70804dd63221dd5ed26068ec1b50f11875abbc50 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2-Endothelial_Stalk.Flt1.Lrg1_(Lrg1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | c1818411438f53aec76afead5c8caab701b95d39 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-04 | 83 | 21 | 2 | 1e7af8aaa20b4c2a77cf2f330113db0faa9d483c | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | c37e1170d39ad015f724e373a547ea5b6ba45a84 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | 7e4a76b65b0d34d9950f8b02590ff5a4b4534a27 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2-Tnr|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | 503490e9408d9638bcd089ef8ec0521924df9a5d | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE-P2|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.07e-04 | 84 | 21 | 2 | 1f8b19b159f83655f66cb99f8d10d9a87c08f78f | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | 926e02725a03d8473eda25d4aef63e34a6566224 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Col15a1_(Col15a1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.47e-04 | 92 | 21 | 2 | d2c1d25e5bb6ba4f406e916e3c0a5ad05492e59d | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 104 | 21 | 2 | 59e982b521610af0532c63b2caf934fa65644b0b | |
| ToppCell | COVID-19-Heart-Fib_+_CM|Heart / Disease (COVID-19 only), tissue and cell type | 1.08e-03 | 104 | 21 | 2 | 0b60a56a46f1fe3f8224ec6399d009a34a117a21 | |
| ToppCell | Control-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.08e-03 | 104 | 21 | 2 | 5f72aa686b0fb83d401621e1b9d9c69e56105570 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 104 | 21 | 2 | 7642c6ac1a51b431a8d48d35520930c072a3710e | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Excitatory_Neuron.Slc17a7.Cplx3_(Cortical_subplate)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.08e-03 | 104 | 21 | 2 | 016704f1d1c43e6d4067ad1d81c22cc660e605d0 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 109 | 21 | 2 | 6e90d04c5094c7410d667dae80de3279bddd24bd | |
| ToppCell | PND07-28-samps-Myeloid-Macrophage-macrophage-A|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.25e-03 | 112 | 21 | 2 | d21cfcb04a27cc9fb74e0c2afa8a8cdfb886ae21 | |
| ToppCell | (05)_Ciliated-(3)_72hpi|(05)_Ciliated / shred by cell type and Timepoint | 1.27e-03 | 113 | 21 | 2 | eaa5bc8f8183b353ee1e7618e99220eb3684cd60 | |
| ToppCell | Control-B_naive-4|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.34e-03 | 116 | 21 | 2 | 35d471c8dbf408d0be3837c428d9c2a73c805a6f | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.55e-03 | 125 | 21 | 2 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_B1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-03 | 126 | 21 | 2 | 10e1448a03f79965b72922fd83ef51de1b7b474f | |
| ToppCell | Globus_pallidus|World / BrainAtlas - Mouse McCarroll V32 | 1.58e-03 | 126 | 21 | 2 | 44b63f945d5bedf1a2ca1810e7e100276ea9dd89 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-03 | 127 | 21 | 2 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-03 | 130 | 21 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.73e-03 | 132 | 21 | 2 | 617644597726e881cd343e57f6edb5a98473b421 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-03 | 133 | 21 | 2 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.89e-03 | 138 | 21 | 2 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-DC2|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.94e-03 | 140 | 21 | 2 | c3331cb7720f93af8bab35d02c6cbe87dd324d91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-03 | 141 | 21 | 2 | 091b5b72811db5fca2314f4a79d467566920e257 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-03 | 141 | 21 | 2 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-03 | 144 | 21 | 2 | 5665dd2839b6c8ddbf5ddb2d22e1ee6073f74c3b | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_DC-DC-tDC|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-03 | 145 | 21 | 2 | a6c291811bf62f1c13f1b4b396d75c2223cf1c7d | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 2.08e-03 | 145 | 21 | 2 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 2.08e-03 | 145 | 21 | 2 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| Computational | Neighborhood of CDH3 | 5.05e-06 | 27 | 14 | 3 | GNF2_CDH3 | |
| Computational | Neighborhood of SERPINB5 | 5.65e-06 | 28 | 14 | 3 | GNF2_SERPINB5 | |
| Computational | Intermediate filaments and MT. | 8.39e-05 | 68 | 14 | 3 | MODULE_438 | |
| Computational | Intermediate filaments. | 1.12e-04 | 75 | 14 | 3 | MODULE_154 | |
| Computational | Genes in the cancer module 297. | 1.36e-04 | 80 | 14 | 3 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 1.36e-04 | 80 | 14 | 3 | MODULE_357 | |
| Computational | Breast cancer expression clusters. | 8.13e-04 | 33 | 14 | 2 | MODULE_366 | |
| Computational | Genes in the cancer module 153. | 8.63e-04 | 34 | 14 | 2 | MODULE_153 | |
| Computational | Genes in the cancer module 285. | 1.79e-03 | 49 | 14 | 2 | MODULE_285 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.86e-03 | 50 | 14 | 2 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Drug | NSC350854 | 2.69e-06 | 108 | 21 | 4 | CID000434448 | |
| Drug | betaine aldehyde | 3.30e-06 | 32 | 21 | 3 | CID000000249 | |
| Drug | Retinaldehyde | 7.59e-06 | 42 | 21 | 3 | ctd:D012172 | |
| Drug | 3-butynoate | 1.70e-05 | 7 | 21 | 2 | CID000137547 | |
| Drug | 3-butynal | 1.70e-05 | 7 | 21 | 2 | CID000142966 | |
| Drug | C04554 | 2.26e-05 | 8 | 21 | 2 | CID000440384 | |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.73e-05 | 194 | 21 | 4 | 7196_DN | |
| Drug | CPD 30 | 2.91e-05 | 9 | 21 | 2 | CID000440850 | |
| Drug | 4-acetamidobutyrate | 2.91e-05 | 9 | 21 | 2 | CID000018189 | |
| Drug | succinic semialdehyde | 3.41e-05 | 69 | 21 | 3 | CID000001112 | |
| Drug | sulfenic acid | 3.41e-05 | 69 | 21 | 3 | CID000447586 | |
| Drug | ynoate | 4.43e-05 | 11 | 21 | 2 | CID000010110 | |
| Drug | AC1L1J0I | 5.32e-05 | 12 | 21 | 2 | CID000030201 | |
| Drug | imidazole acetaldehyde | 5.32e-05 | 12 | 21 | 2 | CID000150841 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 8.45e-05 | 15 | 21 | 2 | CID000440673 | |
| Drug | glycurone | 9.65e-05 | 16 | 21 | 2 | CID000003483 | |
| Drug | trimethylaminobutyraldehyde | 1.09e-04 | 17 | 21 | 2 | CID000000133 | |
| Drug | propynal | 1.09e-04 | 17 | 21 | 2 | CID000012222 | |
| Drug | methylimidazole acetaldehyde | 1.09e-04 | 17 | 21 | 2 | CID000193545 | |
| Drug | N-methylmaleimide | 1.23e-04 | 18 | 21 | 2 | CID000070261 | |
| Drug | 5-HIAL | 1.37e-04 | 19 | 21 | 2 | CID000074688 | |
| Drug | testosterone enanthate | 1.47e-04 | 575 | 21 | 5 | ctd:C004648 | |
| Drug | perillaldehyde | 1.68e-04 | 21 | 21 | 2 | CID000016441 | |
| Drug | gamma-aminobutyraldehyde | 2.40e-04 | 25 | 21 | 2 | CID000000118 | |
| Drug | glyceraldehyde | 2.79e-04 | 140 | 21 | 3 | CID000000751 | |
| Drug | indole-3-acetaldehyde | 3.02e-04 | 28 | 21 | 2 | CID000000800 | |
| Drug | nonanal | 3.24e-04 | 29 | 21 | 2 | CID000031289 | |
| Drug | 3,4-dihydroxyphenylacetaldehyde | 3.47e-04 | 30 | 21 | 2 | CID000119219 | |
| Drug | 3-aminopropanal | 3.47e-04 | 30 | 21 | 2 | CID000000075 | |
| Drug | decanal | 3.71e-04 | 31 | 21 | 2 | CID000008175 | |
| Drug | perillic acid | 3.71e-04 | 31 | 21 | 2 | CID000001256 | |
| Drug | methylmalonate semialdehyde | 3.95e-04 | 32 | 21 | 2 | CID000000296 | |
| Drug | glyceraldehyde-3-phosphate | 4.05e-04 | 159 | 21 | 3 | CID000000729 | |
| Drug | alpha-neoendorphin | 4.20e-04 | 33 | 21 | 2 | CID005311003 | |
| Drug | octanal | 5.29e-04 | 37 | 21 | 2 | CID000000454 | |
| Drug | alpha-CDs | 6.50e-04 | 41 | 21 | 2 | CID000452566 | |
| Drug | AC1LAR7G | 6.50e-04 | 41 | 21 | 2 | CID000493598 | |
| Drug | gamma-butyrobetaine | 6.82e-04 | 42 | 21 | 2 | CID000000134 | |
| Drug | Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 7.13e-04 | 193 | 21 | 3 | 4146_UP | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; PC3; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 2099_DN | |
| Drug | Loxapine succinate [27833-64-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 5293_DN | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 7.45e-04 | 196 | 21 | 3 | 5331_UP | |
| Drug | celecoxib; Down 200; 10uM; MCF7; HG-U133A | 7.68e-04 | 198 | 21 | 3 | 252_DN | |
| Drug | (-)-quinpirole hydrochloride; Down 200; 1uM; MCF7; HG-U133A | 7.79e-04 | 199 | 21 | 3 | 456_DN | |
| Drug | Acetazolamide [59-66-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 7461_UP | |
| Drug | Meprylcaine hydrochloride [956-03-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 7.79e-04 | 199 | 21 | 3 | 3544_UP | |
| Drug | hexanal | 8.54e-04 | 47 | 21 | 2 | CID000006184 | |
| Drug | imidazole-4-acetic acid | 8.91e-04 | 48 | 21 | 2 | CID000096215 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.06e-04 | 37 | 17 | 2 | DOID:0050545 (implicated_via_orthology) | |
| Disease | Asthma | 9.61e-04 | 80 | 17 | 2 | C0004096 | |
| Disease | tea consumption measurement | 2.47e-03 | 129 | 17 | 2 | EFO_0010091 | |
| Disease | parental longevity | 2.66e-03 | 494 | 17 | 3 | EFO_0007796 | |
| Disease | Takayasu arteritis | 3.23e-03 | 148 | 17 | 2 | EFO_1001857 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCNNFNHCHCEKGYN | 366 | Q6NVV9 | |
| CNAEFQNFCIHGECK | 146 | P15514 | |
| CAHQGVFFNQGQCCT | 301 | P47895 | |
| CASNGHTFQNECFFC | 61 | Q1W4C9 | |
| QCFVCAQCFQQFPEG | 96 | P0CW19 | |
| QCFVCAQCFQQFPEG | 96 | P0CW20 | |
| CFNHSCPDDQFKCQN | 881 | Q9NZR2 | |
| YCDCFANGEFCNNCN | 536 | Q6MZP7 | |
| CNNCNCTNCYNNLEH | 546 | Q6MZP7 | |
| CFCFGVNNQCHSSHK | 1456 | Q16787 | |
| YFNGQDCQPCHRFCA | 776 | Q92824 | |
| HACAALQNNFQEFCQ | 701 | Q92817 | |
| NVYHLDCFACQLCNQ | 96 | Q8TAP4 | |
| CHNYQLCQNCFWRGH | 261 | O60941 | |
| LDCHVCAYNGDNCFN | 21 | P0DP58 | |
| FASGDFCNNCNCNNC | 311 | Q9Y4I5 | |
| FCNNCNCNNCCNNLH | 316 | Q9Y4I5 | |
| YHEQCFVCAQCFQQF | 31 | P48059 | |
| QAHFALFFNQGQCCC | 306 | P05091 | |
| NPQVYFCCCEGNFCN | 96 | Q13705 | |
| TQCRHQFCSGCYNAF | 891 | Q96EP0 | |
| FHSANNFIMNCCENC | 221 | Q5SVZ6 | |
| HCIQASSCNCFYNND | 1086 | Q9Y493 |